Curadim Pharma Co., Ltd.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://curadim.co.jp
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
2 (100.0%)A First-in-human Phase 1 Study of CP1050
Phase 1
- Conditions
- Healthy Subjects
- Interventions
- Drug: CP1050 or Placebo
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2018-03-16
- Lead Sponsor
- Curadim Pharma Co., Ltd.
- Target Recruit Count
- 116
- Registration Number
- NCT03468413
- Locations
- π¬π§
Covance Clinical Research Unit (CRU) Ltd., Leeds, United Kingdom
News
No news found